Phase 2 Study to Evaluate Dose and Duration of Treatment of Drotrecogin Alfa (Activated)Using Serial Measurements of Protein C in Patients with Severe Sepsis..
|Effective start/end date
|3/13/07 → 9/16/10
- ELI LILLY AND COMPANY
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.